Comment by
Lesalpes29 on Oct 19, 2022 8:15am
Noteable posts are a test of patience too!
Comment by
Lesalpes29 on Oct 21, 2022 11:56am
I Don't see it that way. New directors are with us for a simple buyout after a big battle between BP. Really hope!
Comment by
Noteable on Oct 21, 2022 12:14pm
For those who "don't see it that way" ... well then I suggest that they are significantly short sighted.
Comment by
Lesalpes29 on Oct 21, 2022 12:20pm
Relax bunny it's only an opinion!
Comment by
Lesalpes29 on Oct 21, 2022 12:25pm
By the way Noteable we are on the same side!
Comment by
Noteable on Oct 21, 2022 1:04pm
Well that "bunny" opinion is perhaps way out in "left field" since it has repeatedly been stated on this message board that an acquisition by Big Pharma north of US$8 Billion is well within reach and that the two new ONCY board members were tasked with reaching this objective.
Comment by
Lesalpes29 on Oct 21, 2022 1:11pm
We both agree. Have a great weekend
Comment by
fox7mf on Oct 21, 2022 1:22pm
In your opinion Noteable, do you think Roche is in, or has taken the driver's seat in acquisition negotiations based on what should/hopefully be continued stellar pancreatic data?
Comment by
Noteable on Oct 21, 2022 1:34pm
DNK other than both Roche and Pfizer (as well as others) have multiple reasons for acquiring ONCY, including those involving pancreatic cancer.
Comment by
jimsenior on Oct 21, 2022 1:54pm
DNK either. I have considered that a collaboration might be in the making. Merck, Roche and Pfizer. I was told years ago that that was a dumb idea. Nevertheless such a collaboration might be in the best interests of all parties, especially, presumably, a much larger number of patients. Just an idle thought. Cheers.
Comment by
Noteable on Oct 21, 2022 2:18pm
ONCY has consistently stated that it would seek a collaboration, which it has with MerckKaAG/Pfizer, Roche and Incyte, that would ultimately lead to an acquistion Any ideas to the contrary would have been "floated" by those interested in pushing a negative narrative.
Comment by
Noteable on Oct 21, 2022 4:26pm
It's implied in their appointment. No company is that naive to publically state intent.
Comment by
inthno on Oct 21, 2022 4:33pm
Thanks for clarifying your statement as implied is different than what you had stated so nice to see you clear that up. Here's to an interesting and hopefully great November and start to what we all are hoping to happen.
Comment by
fox7mf on Oct 21, 2022 1:08pm
Man, another $11.6b of PFE's cash being spent on a biotech other than ONC!! Is PFE gonna have any cash left!?! Coffey better let Parsons & Rigby do what they're tasked to do...
Comment by
Noteable on Oct 21, 2022 1:31pm
As of June 30, 2022 Pfizer reported a revenue increase of $20.0 billion, or 60%, in the first six months of 2022 to $53.4 billion from $33.4 billion in the first six months of 2021, reflecting an operational increase of $22.0 billion, or 66% from the same time last year. Pfiser has plenty enough cash on hand for an ONCY acquisition.
Comment by
Noteable on Oct 21, 2022 1:41pm
Also, as of June 30, 2022 Pfizer reported total assets equalling $195.3 billion
Comment by
westcoast1000 on Oct 21, 2022 12:12pm
OK, Noteable, this is one of your most encouraging and relevant posts, in terms of transactions.
Comment by
Noteable on Oct 21, 2022 2:50pm
And while others call-out paranoia, I stand on experience. I have seen too many bunco artists who chirp paranoia not to recognize them as they really are.
Comment by
Buckhenry on Oct 21, 2022 4:39pm
oh how I wish for the time things were simpler... no facebook Twitter tiktok or some wall street twit site where folks post any BS under the sun to see how many followers they can get. simply put we were better off without the internet and made money just fine without it. looking forward to that EMP (electromagnetic pulse) to get rid of all the electronics. I still carry cash.
Comment by
Capitalista on Oct 22, 2022 5:14am
I'm with you, Buckhenry. Except for the cash part. Although I'd probably carry it if I had any.
Comment by
Noteable on Oct 21, 2022 2:56pm
Machiavelli senior - Yes - years of experience easliy reveals your style of beguilement.
Comment by
Buckhenry on Oct 21, 2022 2:58pm
noteable's postings are ok for the most part but woe be it to those of us who throw in some realism along the way. this is an open forum. if you can't respect that then get out. most of us have held for a long time and tired of all the BS.
Comment by
Noteable on Oct 25, 2022 1:28pm
October 25, 2022 - Cancer, specifically breast cancer, is the topic for Pfizer’s second season of its “Science Will Win” podcast debuting this week. https://endpts.com/marketingrx-roundup-pfizer-bows-season-2-of-science-will-win-podcast-gileads-kite-sponsors-cancer-light-up-nights/
Comment by
Noteable on Oct 25, 2022 3:49pm
Further on the topic of ONY's expected US$8 Billion+ M&A acquisition price, J&J's top-selling immunology drug Stelara, which has brought in over $7 Billion in the first nine months of the year, is set to lose patent protection next year. And, like other big pharma companies, J&J is also extremely cash-rich, with about $34 billion on hand.
Comment by
Noteable on Oct 25, 2022 3:50pm
Should read: "...Further on the topic of ONCY's expected US$8 Billion+ M&A acquisition price ...
Comment by
fox7mf on Oct 26, 2022 8:36am
Noteable, your language has changed & we're now reading "expected" +$8b usd. Love the confidence &...do you know something we don't?
Comment by
Noteable on Oct 26, 2022 11:04am
Better stated as 'expectations' rather than the alternative.
Comment by
Buckhenry on Oct 25, 2022 4:40pm
but that's does not imply that they will give that much for oncy.. ... just wishful hoping
Comment by
jimsenior on Nov 01, 2022 1:09pm
Nota Bene - Pfizer's NICE approval.
Comment by
jimsenior on Nov 01, 2022 2:03pm
See ONC Press Release April 12, 2021
Comment by
jimsenior on Nov 01, 2022 2:07pm
There were 2 releases on that date. Preclinical Data is the one of interest today.